Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study.
about
Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b.The co-existence of NS5A and NS5B resistance-associated substitutions is associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir.Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?
P2860
Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Efficacy and safety of ledipas ...... naprevir therapy: pilot study.
@en
type
label
Efficacy and safety of ledipas ...... naprevir therapy: pilot study.
@en
prefLabel
Efficacy and safety of ledipas ...... naprevir therapy: pilot study.
@en
P2093
P2860
P1476
Efficacy and safety of ledipas ...... naprevir therapy: pilot study.
@en
P2093
Clair Nelson Hayes
Hidenori Ochi
Hiroshi Kohno
Hirotaka Kohno
Kazuaki Chayama
Kazunari Masuda
Keiji Tsuji
Keiko Arataki
Masataka Tsuge
Masaya Kikkawa
P2860
P356
10.1007/S00535-017-1380-8
P577
2017-08-16T00:00:00Z